Abstract:Db/db mice exhibited low vagal activity and diabetic myocardial injury, accompanied by gut microbiota dysbiosis and gut barrier dysfunction, as well as increased lipopolysaccharide (LPS) concentrations and metabolic inflammation. Importantly, pyridostigmine could protect against diabetic myocardial injury by alleviating gut microbiota dysbiosis and gut barrier dysfunction and reducing metabolic inflammation, possibly by inhibiting the LPS‐induced activation of the ERK/Egr‐1 pathway. Moreover, acetylcholine ameliorated high‐glucose (HG) and LPS‐induced cardiomyocytes injury by inhibiting the ERK/Egr‐1 pathway and inflammation through α7nAChR. Autonomic imbalance and metabolic inflammation are important pathological processes in diabetic cardiomyopathy. Gut microbiota dysbiosis and increased levels of bacterial component lipopolysaccharide (LPS) are associated with diabetic myocardial injury, but the mechanism by which gut microbes affect metabolic inflammation and cardiac injury remains unclear. We determined whether pyridostigmine (PYR), which inhibits cholinesterase to improve vagal activity, could regulate the disordered gut microbiota and attenuate gut barrier dysfunction, metabolic endotoxemia, and inflammation in diabetes. Db/db mice exhibited high blood glucose levels, insulin resistance, low vagal activity, and diabetic myocardial injury. Db/db mice also exhibited gut microbiota perturbations and subsequent disruption of gut barrier function, resulting in an influx of LPS, metabolic endotoxemia, and inflammation. PYR ameliorated the dysregulated glucose and lipid metabolism, modulated the overall structure of the gut microbiota, selectively enhanced the abundance of anti‐inflammatory bacteria, and reduced the abundance of proinflammatory and potentially pathogenic bacteria in db/db mice. Importantly, PYR enhanced vagal activity, restored gut microbiota homeostasis, and alleviated gut barrier dysfunction. Therefore, the LPS‐induced extracellular signal‐regulated kinase (ERK)/early growth response‐1 (Egr‐1) pathway and consequent metabolic inflammation were inhibited, and eventually, cardiac hypertrophy, fibrosis, oxidative stress, and dysfunction were ameliorated in db/db mice. In vitro cardiomyocyte injury was induced by exposing primary neonatal rat ventricular cardiomyocytes to high glucose (HG) and LPS. In vitro analyses showed that HG + LPS induced ERK1/2 phosphorylation, Egr‐1 expression, inflammation, and cell apoptosis, which were inhibited by acetylcholine (ACh). Alpha 7 nicotinic ACh receptor but not muscarinic 2 ACh receptor plays an important role in ACh‐mediated anti‐inflammatory effects and inhibiting the ERK/Egr‐1 pathway in HG + LPS‐administered neonatal rat ventricular cardiomyocytes. PYR and ACh ameliorated diabetic myocardial injury by inhibiting the LPS‐induced ERK/Egr‐1 pathway and metabolic inflammation. The vagus–gut–heart axis has provided new insights into the complex mechanisms of diabetes and offers novel therapeutic targets.

Cholinergic Drugs Ameliorate Endothelial Dysfunction by Decreasing O-GlcNAcylation Via M3 AChR-AMPK-ER Stress Signaling.

Acetylcholine ameliorates endoplasmic reticulum stress in endothelial cells after hypoxia/reoxygenation via M3 AChR-AMPK signaling

Pyridostigmine attenuated high‐fat‐diet induced liver injury by the reduction of mitochondrial damage and oxidative stress via α7nAChR and M3AChR

Cholinergic drugs reduce metabolic inflammation and diabetic myocardial injury by regulating the gut bacterial component lipopolysaccharide‐induced ERK/Egr‐1 pathway

Choline Ameliorates Cardiac Hypertrophy by Regulating Metabolic Remodelling and UPRmt Through SIRT3-AMPK Pathway

Dietary choline increases brown adipose tissue activation markers and improves cholesterol metabolism in female APOE*3-Leiden.CETP mice

Dietary Choline Alleviates High-Fat Diet-Induced Hepatic Lipid Dysregulation via UPRmt Modulated by SIRT3-Mediated mtHSP70 Deacetylation

A GLP-1 analog lowers ER stress and enhances protein folding to ameliorate homocysteine-induced endothelial dysfunction

Chemical Chaperones Reduce ER Stress and Adipose Tissue Inflammation in High Fat Diet-Induced Mouse Model of Obesity

Activation Of M3achr (Type 3 Muscarinic Acetylcholine Receptor) And Nrf2 (Nuclear Factor Erythroid 2-Related Factor 2) Signaling By Choline Alleviates Vascular Smooth Muscle Cell Phenotypic Switching And Vascular Remodeling

Abstract P278: Coronary Microvascular Dysfunction Is Associated With Augumented Autophagy-lysosomal Signaling In Mice With Hypercholesterolemic Diet

Pyridostigmine Alleviates Cardiac Dysfunction Via Improving Mitochondrial Cristae Shape in a Mouse Model of Metabolic Syndrome.

The Effects of Choline on Hepatic Lipid Metabolism, Mitochondrial Function and Antioxidative Status in Human Hepatic C3A Cells Exposed to Excessive Energy Substrates

Db120162 3219..3227

The Chemical Chaperone Tauroursodeoxycholic Acid Alleviates Cardiac Contractile Dysfunction in Obesity: Role of Endoplasmic Reticulum‐Stress in Cardiac Functionality

Acetylcholine promotes ROS detoxification against hypoxia/reoxygenation-induced oxidative stress through FoxO3a/PGC-1α dependent superoxide dismutase.

Inhibition of the Mitochondrial Unfolded Protein Response by Acetylcholine Alleviated Hypoxia/reoxygenation-Induced Apoptosis of Endothelial Cells

Antioxidants Supplementation Reduces Ceramide Synthesis Improving the Cardiac Insulin Transduction Pathway in a Rodent Model of Obesity

Metformin Protects Endothelial Function in Diet-Induced Obese Mice by Inhibition of Endoplasmic Reticulum Stress Through 5′ Adenosine Monophosphate–Activated Protein Kinase–Peroxisome Proliferator–Activated Receptor Δ Pathway

Acetylcholine Inhibits Tumor Necrosis Factor Α Activated Endoplasmic Reticulum Apoptotic Pathway Via EGFR‐PI3K Signaling in Cardiomyocytes

Pharmacological activation of AMPK ameliorates perivascular adipose/endothelial dysfunction in a manner interdependent on AMPK and SIRT1.